Abstract
Chikungunya fever (CHIK) has caused important epidemic outbreaks in the Americas, with musculoskeletal involvement being the main manifestation, causing chronic symptoms in half of the affected patients. This study was performed to evaluate the clinical course of the infection in 168 patients with autoimmune inflammatory disease using biological disease-modifying antirheumatic drugs (bDMARDs), comparing this group with 56 household controls. Anti-CHIKV IgG serology was positive in 42 (25%) of the patients in the bDMARD group and in 15 (27%) of the controls (p=0.79). Of those with positive serology, 32 (76%) and 14 (93%) were symptomatic among subjects in the bDMARD and control groups, respectively (p=0.87). Persistence of musculoskeletal symptoms for more than three months occurred in 64% of the patients in the control group and only in 28% in the bDMARD group (p=0.021), maintaining a statistically significant difference only for users of anti-TNF. This study found that patients affected by chikungunya fever using bDMARDs did not present severe forms or complications in the acute phase of the disease, and patients using anti-TNF biologicals had a lower frequency of chronic joint symptoms than the household controls. This favora...Continue Reading
References
Feb 19, 2003·FEMS Immunology and Medical Microbiology·Alena AtrasheuskayaGeorge Ignatyev
Jan 27, 2004·Current Medical Research and Opinion·Edward Tobinick
Aug 13, 2008·Epidemiology and Infection·A EconomopoulouI Quatresous
Feb 1, 2011·Arthritis and Rheumatism·Ali ZaidSuresh Mahalingam
Sep 27, 2013·BioMed Research International·Iranaia Assunção-MirandaAndrea T Da Poian
Jan 1, 2014·Critical Care : the Official Journal of the Critical Care Forum·Xunlong ShiDianwen Ju
Sep 10, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Christophe DelignySerge Arfi
Oct 25, 2014·PloS One·Anuradha VenugopalanArvind Chopra
Nov 25, 2014·Emerging Infectious Diseases·Christine M PratIsabelle Leparc-Goffart
May 29, 2015·Clinical Rheumatology·V RosarioR Alba-Fériz
Apr 16, 2016·F1000Research·Alfonso J Rodriguez-MoralesGuillermo J Lagos-Grisales
Jan 21, 2017·PLoS Neglected Tropical Diseases·Rivaldo V CunhaJulio Croda
Jul 29, 2017·Revista Brasileira De Reumatologia·Claudia Diniz Lopes MarquesGeorges Christopoulos
Nov 22, 2017·Revista Da Sociedade Brasileira De Medicina Tropical·Carlos Alexandre Antunes de Brito
Feb 11, 2018·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Fernández-RuizJ Delaloye
Mar 30, 2018·Annals of the Rheumatic Diseases·Andrew I RutherfordJames B Galloway
Oct 3, 2018·Expert Review of Gastroenterology & Hepatology·Zachary A BormanJean-Frédéric Colombel
Oct 27, 2018·Frontiers in Cellular and Infection Microbiology·Ithallo S B TanabeÊnio J Bassi
Dec 7, 2018·PloS One·Timothee BonifayUNKNOWN Char Chik Working group
Sep 7, 2019·Nature Communications·Claudia P FigueiredoSergio T Ferreira
Mar 3, 2020·The Lancet Infectious Diseases·Justin StebbingPeter Richardson